Related Experiment Video
Updated: Sep 8, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Catastrophic Events of Cardiac Sarcoidosis: A Case Report
Maria Riasat1, Arshan Khan2, Moiz Ehtesham3
1Internal Medicine, Icahn School of Medicine Mount Sinai Beth Israel, New York, USA.
Insights
Cardiac sarcoidosis (CS) can be asymptomatic but lead to sudden death. This case highlights how advanced imaging like FDG-PET can detect myocardial inflammation, guiding treatment and showing recovery in a patient with pulmonary sarcoidosis.
Area of Science:
- Cardiology
- Pulmonology
- Nuclear Medicine
Background:
- Cardiac sarcoidosis (CS) often presents insidiously, with atrioventricular block or fatal arrhythmias.
- Endomyocardial biopsy has limited sensitivity for diagnosing CS due to patchy myocardial involvement.
Observation:
- A female patient presented with syncope and cardiac arrests, initially with unremarkable autoimmune workup.
- Cardiac MRI showed non-ischemic intramyocardial enhancement, and FDG-PET revealed patchy myocardial uptake.
Findings:
- Intravenous methylprednisolone treatment led to clinical improvement.
- Repeat FDG-PET demonstrated resolution of myocardial inflammation.
- Bronchoscopy with biopsy confirmed pulmonary sarcoidosis with granulomas.
Implications:
- FDG-PET imaging is valuable for diagnosing cardiac sarcoidosis and monitoring treatment response.
- Early detection and treatment of CS can prevent life-threatening cardiac events.
- Integrated diagnostic approaches combining imaging and biopsy are crucial for managing CS.
Abstract:
Cardiac sarcoidosis (CS) can be silent in most patients with extrapulmonary sarcoidosis. Atrioventricular (AV) block is the most common clinical presentation, but it can also present as fatal ventricular arrhythmias and sudden cardiac death. Endomyocardial biopsy is the gold standard; however, it is not sensitive since CS can involve the myocardium in a patchy distribution. Our case depicts a female who presented with syncope; however, her hospital course was complicated by multiple cardiac arrests. Her initial laboratory tests, including an autoimmune workup, were unremarkable. Cardiac magnetic resonance and fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging revealed intramyocardial delayed enhancement of the basal anteroseptal (non-ischemic distribution) and patchy foci of increased uptake in the anteroseptal and inferior myocardial region, respectively. The patient was started on intravenous methylprednisolone, and her condition slowly improved. Post-discharge, the patient followed in the outpatient clinic with a repeat FDG-PET scan revealing resolution of myocardial FDG uptake. She also underwent bronchoscopy with lymph node biopsy showing granulomas and endobronchial biopsy confirming pulmonary sarcoidosis.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care

